2-hydroxy-4-[3-[4-methyl-2-[[3-(trifluoromethyl)phenyl]methyl]-1,3-thiazol-5-yl]phenyl]benzoic acid
C25H18F3NO3S — CID 162757311
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-hydroxy-4-[3-[4-methyl-2-[[3-(trifluoromethyl)phenyl]methyl]-1,3-thiazol-5-yl]phenyl]benzoic acid
2-hydroxy-4-[3-[4-methyl-2-[[3-(trifluoromethyl)phenyl]methyl]-1,3-thiazol-5-yl]phenyl]benzoic acid (PubChem CID 162757311) has the molecular formula C25H18F3NO3S and a molecular weight of 469.48 g/mol. Its IUPAC name is 2-hydroxy-4-[3-[4-methyl-2-[[3-(trifluoromethyl)phenyl]methyl]-1,3-thiazol-5-yl]phenyl]benzoic acid.
Molecular Properties
| Compound Name | 2-hydroxy-4-[3-[4-methyl-2-[[3-(trifluoromethyl)phenyl]methyl]-1,3-thiazol-5-yl]phenyl]benzoic acid |
|---|---|
| PubChem CID | 162757311 |
| Molecular Formula | C25H18F3NO3S |
| Molecular Weight | 469.48 g/mol |
| Exact Mass | 469.10 |
| IUPAC Name | 2-hydroxy-4-[3-[4-methyl-2-[[3-(trifluoromethyl)phenyl]methyl]-1,3-thiazol-5-yl]phenyl]benzoic acid |
| SMILES | Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1cccc(-c2ccc(C(=O)O)c(O)c2)c1 |
| InChI | InChI=1S/C25H18F3NO3S/c1-14-23(33-22(29-14)11-15-4-2-7-19(10-15)25(26,27)28)18-6-3-5-16(12-18)17-8-9-20(24(31)32)21(30)13-17/h2-10,12-13,30H,11H2,1H3,(H,31,32) |
| InChIKey | AJHXXLSXSJUFJS-UHFFFAOYSA-N |
| XLogP | 6.80 |
| TPSA | 70.42 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 469.48 |
| LogP ≤ 5 | 6.80 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162757311 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.